DYN
Price
$8.25
Change
-$1.17 (-12.42%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.07B
26 days until earnings call
RNA
Price
$26.57
Change
-$1.53 (-5.44%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
3.38B
38 days until earnings call
Ad is loading...

DYN vs RNA

Header iconDYN vs RNA Comparison
Open Charts DYN vs RNABanner chart's image
Dyne Therapeutics
Price$8.25
Change-$1.17 (-12.42%)
Volume$52.9K
Capitalization1.07B
Avidity Biosciences
Price$26.57
Change-$1.53 (-5.44%)
Volume$26.71K
Capitalization3.38B
DYN vs RNA Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. RNA commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and RNA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (DYN: $9.42 vs. RNA: $28.10)
Brand notoriety: DYN and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 90% vs. RNA: 153%
Market capitalization -- DYN: $1.07B vs. RNA: $3.38B
DYN [@Biotechnology] is valued at $1.07B. RNA’s [@Biotechnology] market capitalization is $3.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 3 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • RNA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DYN is a better buy in the short-term than RNA.

Price Growth

DYN (@Biotechnology) experienced а -20.17% price change this week, while RNA (@Biotechnology) price change was -13.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

DYN is expected to report earnings on May 01, 2025.

RNA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.38B) has a higher market cap than DYN($1.07B). RNA YTD gains are higher at: -3.370 vs. DYN (-60.017). DYN has higher annual earnings (EBITDA): -342.21M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. DYN (642M). RNA has less debt than DYN: RNA (6.8M) vs DYN (24M). RNA has higher revenues than DYN: RNA (10.9M) vs DYN (0).
DYNRNADYN / RNA
Capitalization1.07B3.38B32%
EBITDA-342.21M-376.16M91%
Gain YTD-60.017-3.3701,781%
P/E RatioN/AN/A-
Revenue010.9M-
Total Cash642M1.5B43%
Total Debt24M6.8M353%
TECHNICAL ANALYSIS
Technical Analysis
DYNRNA
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 20 days ago
86%
Bullish Trend 13 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-4.94%
CRNX - DYN
48%
Loosely correlated
-8.03%
MRSN - DYN
47%
Loosely correlated
-9.94%
RNA - DYN
46%
Loosely correlated
-5.61%
INZY - DYN
45%
Loosely correlated
-5.49%
IGMS - DYN
45%
Loosely correlated
-5.69%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with RYTM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
-5.61%
RYTM - RNA
46%
Loosely correlated
-4.12%
DYN - RNA
44%
Loosely correlated
-4.94%
ACLX - RNA
44%
Loosely correlated
-7.12%
URGN - RNA
43%
Loosely correlated
-5.98%
CRNX - RNA
41%
Loosely correlated
-8.03%
More